Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-139-5p AKT3 -1.46 0 0.76 5.0E-5 PITA; miRanda -0.2 7.0E-5 NA
2 hsa-miR-15a-5p AKT3 0.78 0 0.76 5.0E-5 miRNAWalker2 validate; miRTarBase; miRNATAP -0.27 0.00011 NA
3 hsa-miR-17-5p AKT3 1.42 0 0.76 5.0E-5 TargetScan; miRNATAP -0.21 1.0E-5 NA
4 hsa-miR-205-3p AKT3 1.3 0 0.76 5.0E-5 mirMAP -0.25 0 NA
5 hsa-miR-20a-5p AKT3 1.15 0 0.76 5.0E-5 miRNATAP -0.24 0 NA
6 hsa-miR-29b-3p AKT3 -0.11 0.51126 0.76 5.0E-5 miRNATAP -0.26 0 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
7 hsa-miR-362-3p AKT3 -0.7 0 0.76 5.0E-5 miRanda -0.2 0.00031 NA
8 hsa-miR-362-5p AKT3 0.41 0.04043 0.76 5.0E-5 PITA; TargetScan; miRNATAP -0.16 0.00012 NA
9 hsa-miR-127-3p BAD -1.47 0 0.23 0.0411 miRanda; miRNATAP -0.11 1.0E-5 NA
10 hsa-miR-326 BAD -0.43 0.0415 0.23 0.0411 miRanda -0.16 0 NA
11 hsa-miR-193b-3p CASP9 1.73 0 -0.46 0 miRNAWalker2 validate -0.15 0 NA
12 hsa-miR-424-5p CASP9 1.48 0 -0.46 0 mirMAP -0.14 0 NA
13 hsa-miR-7-5p CASP9 1.56 0 -0.46 0 miRNAWalker2 validate -0.1 0 NA
14 hsa-miR-106b-5p CDC42 0.5 1.0E-5 0.01 0.84641 miRNAWalker2 validate -0.13 0 NA
15 hsa-miR-107 CDC42 -0.04 0.67162 0.01 0.84641 miRanda -0.13 0 23627613 Quantitative real-time PCR was used to analyze the expression of miR-107 and its bioinformatically identified targets PIM-1 and CDC42
16 hsa-miR-28-3p CDC42 0.46 0 0.01 0.84641 PITA -0.13 7.0E-5 NA
17 hsa-let-7a-5p HRAS -0.44 3.0E-5 0.26 0.05562 miRNAWalker2 validate; miRTarBase -0.3 0 20607356; 23134218; 18344688; 20033209; 19323605 Transfection of let-7 miRNA reduced expression of pan-RAS N-RAS and K-RAS in the glioblastoma cells;MicroRNA let 7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K Ras and HMGA2 gene expression; K-RAS and HMGA2 mRNA levels were significantly higher in the let-7a overexpressed group than those in the let-7a inhibited group p < 0.05; However the protein levels of K-RAS and HMGA2 were significantly lower in the let-7a overexpressed group than those in the let-7a inhibited group p < 0.05; We suppose that let-7a inhibits the proliferation and invasion of the cell line 95D by regulating the translation of K-RAS and HMGA2 mRNA not the transcription of the mRNA itself;Using an established orthotopic mouse lung cancer model we show that intranasal let-7 administration reduces tumor formation in vivo in the lungs of animals expressing a G12D activating mutation for the K-ras oncogene;k-Ras and c-Myc two key oncogenes in lung cancer have been found to be targeted by let-7 in vitro; The aim of the present study is to determine the effect of let-7a a member of let-7 family on the growth of lung cancer in vivo and to investigate whether let-7-induced suppression of k-Ras and c-Myc is involved in lung cancer; Overexpression of let-7a can inhibit the growth of lung cancer transplanted subcutaneously in nude mice by suppression of k-Ras and c-Myc;Because let-7 microRNA targets the K-ras oncogene we aimed to characterize let-7 expression and function in PDAC in vitro and in vivo; Restoring let-7 levels in cancer-derived cell lines strongly inhibits cell proliferation K-ras expression and mitogen-activated protein kinase activation but fails to impede tumor growth progression after intratumoral gene transfer or after implantation of Capan-1 cells stably overexpressing let-7 microRNA
18 hsa-let-7b-5p HRAS -0.25 0.02114 0.26 0.05562 miRTarBase -0.22 0.0001 20607356; 20881268; 18344688; 20033209; 19323605 Transfection of let-7 miRNA reduced expression of pan-RAS N-RAS and K-RAS in the glioblastoma cells;On the basis of these data we suggest that the downregulation of let-7b and let-7e targeting K-ras and the upregulation of miR-17* a CRC marker could be considered as candidate molecular markers of cetuximab resistance;Using an established orthotopic mouse lung cancer model we show that intranasal let-7 administration reduces tumor formation in vivo in the lungs of animals expressing a G12D activating mutation for the K-ras oncogene;k-Ras and c-Myc two key oncogenes in lung cancer have been found to be targeted by let-7 in vitro; The aim of the present study is to determine the effect of let-7a a member of let-7 family on the growth of lung cancer in vivo and to investigate whether let-7-induced suppression of k-Ras and c-Myc is involved in lung cancer;Because let-7 microRNA targets the K-ras oncogene we aimed to characterize let-7 expression and function in PDAC in vitro and in vivo; Restoring let-7 levels in cancer-derived cell lines strongly inhibits cell proliferation K-ras expression and mitogen-activated protein kinase activation but fails to impede tumor growth progression after intratumoral gene transfer or after implantation of Capan-1 cells stably overexpressing let-7 microRNA
19 hsa-miR-143-3p HRAS -1.34 0 0.26 0.05562 miRNAWalker2 validate; miRTarBase -0.25 0 21276449 The Evi1 microRNA 143 K Ras axis in colon cancer
20 hsa-miR-181d-5p HRAS 0.37 0.00537 0.26 0.05562 miRNAWalker2 validate; miRTarBase -0.12 0.00678 NA
21 hsa-miR-330-5p JMJD7-PLA2G4B 0.94 0 -0.8 0 miRNATAP -0.19 0.00036 NA
22 hsa-miR-542-3p JMJD7-PLA2G4B 0.64 0 -0.8 0 miRNATAP -0.32 0 NA
23 hsa-miR-149-5p KDR 0.44 0.0642 -0.06 0.72302 miRNATAP -0.16 0 NA
24 hsa-miR-15a-5p KDR 0.78 0 -0.06 0.72302 miRNATAP -0.54 0 NA
25 hsa-miR-15b-5p KDR 0.85 0 -0.06 0.72302 miRNATAP -0.23 0.00023 NA
26 hsa-miR-16-5p KDR 0.52 0 -0.06 0.72302 miRTarBase; miRNATAP -0.25 0.00053 26934556 The expression levels of two target genes Myb and VEGFR2 were affected significantly by miR-16 while glucose administration inhibited miR-16 expression and enhanced tumor cell proliferation and migration; Hyperglycemia can impact the clinical outcomes of CRC patients likely by inhibiting miR-16 expression and the expression of its downstream genes Myb and VEGFR2
27 hsa-miR-19b-1-5p KDR 0.76 0 -0.06 0.72302 miRNAWalker2 validate -0.4 0 NA
28 hsa-miR-200b-3p KDR 0.07 0.68286 -0.06 0.72302 miRNAWalker2 validate; miRTarBase; TargetScan -0.26 0 NA
29 hsa-miR-200c-3p KDR 0.63 0.00013 -0.06 0.72302 miRNATAP -0.26 0 24205206 MiR 200c increases the radiosensitivity of non small cell lung cancer cell line A549 by targeting VEGF VEGFR2 pathway; MiR-200c at the nexus of epithelial-mesenchymal transition EMT is predicted to target VEGFR2; The purpose of this study is to test the hypothesis that regulation of VEGFR2 pathway by miR-200c could modulate the radiosensitivity of cancer cells; Bioinformatic analysis luciferase reporter assays and biochemical assays were carried out to validate VEGFR2 as a direct target of miR-200c; We identified VEGFR2 as a novel target of miR-200c
30 hsa-miR-338-3p KDR -0.95 0 -0.06 0.72302 PITA; miRanda -0.2 0 NA
31 hsa-miR-429 KDR 0.56 0.00564 -0.06 0.72302 PITA; miRanda; miRNATAP -0.27 0 NA
32 hsa-miR-455-5p KDR 1.41 0 -0.06 0.72302 PITA; miRanda; miRNATAP -0.28 0 NA
33 hsa-miR-590-3p KDR 0.22 0.09659 -0.06 0.72302 miRanda -0.17 0.0041 NA
34 hsa-miR-590-5p KDR 0.76 0 -0.06 0.72302 miRanda -0.42 0 NA
35 hsa-miR-664a-3p KDR -0.26 0.05132 -0.06 0.72302 mirMAP -0.19 0.00135 NA
36 hsa-let-7a-3p KRAS 0.1 0.42376 -0.04 0.6721 mirMAP; miRNATAP -0.14 0.00014 24727325; 20603437; 24890702; 23324806; 21994416; 23167843; 27620744; 20177422; 25183481; 22584434; 18922928 Association study of the let 7 miRNA complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer NCCTG N0147 Clinical Trial; A let-7 microRNA-complementary site LCS6 polymorphism in the 3' untranslated region of the KRAS gene has been shown to disrupt let-7 binding and upregulate KRAS expression;A let 7 microRNA binding site polymorphism in 3' untranslated region of KRAS gene predicts response in wild type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy; A polymorphism in a let-7 microRNA complementary site lcs6 in the KRAS 3' untranslated region UTR is associated with an increased cancer risk in non-small-cell lung cancer and reduced overall survival OS in oral cancers; the presence of KRAS let-7 lcs6 polymorphism was evaluated in 130 mCRC patients who were enrolled in a phase II study of cetuximab monotherapy IMCL-0144; KRAS let-7 lcs6 polymorphism was found to be related to object response rate ORR in mCRC patients whose tumors had KRASwt;Let 7 microRNA binding site polymorphism in the 3'UTR of KRAS and colorectal cancer outcome: a systematic review and meta analysis; There is a small but growing body of literature regarding the predictive utility of a Let-7 microRNA-binding-site polymorphism in the 3'-untranslated region UTR of KRAS KRAS-LCS6 for colorectal cancer outcome although the results are conflicting; A PubMed search was conducted to identify all studies reporting on KRAS let-7 microRNA-binding site polymorphism LCS6; rs61764370 and colorectal cancer outcome;The LCS6 polymorphism in the binding site of let 7 microRNA to the KRAS 3' untranslated region: its role in the efficacy of anti EGFR based therapy in metastatic colorectal cancer patients; The lethal-7 let-7 family of microRNAs regulates KRAS activity; We studied the association of the KRAS let-7 LCS6 polymorphism with the response in 100 refractory mCRC patients treated with anti-EGFR antibodies; The KRAS let-7 LCS6 polymorphism was genotyped using the BioMark system in blood and tumor DNA samples; The KRAS let-7 LCS6 G-allele showed a statistically significant association with nonresponse to anti-EGFR-based treatment: 31.9% of patients with the T/T genotype presented a complete or a partial response versus no patients with T/G or G/G genotypes P=0.004;A let 7 microRNA SNP in the KRAS 3'UTR is prognostic in early stage colorectal cancer; Recently a SNP in a lethal-7 let-7 miRNA complementary site LCS6 in the KRAS 3'untranslated region was suggested to affect survival in metastatic CRC;Let 7 miRNA binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5 fluorouracil and oxaliplatin +/ cetuximab; Recent studies have reported associations between a variant allele in a let-7 microRNA complementary site LCS6 within the 3'untranslated region 3'UTR of KRAS rs61764370 and clinical outcome in metastatic colorectal cancer mCRC patients receiving cetuximab;A let 7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population; The let-7 microRNAs play a key role in regulating KRAS expression and a polymorphism in 3' untranslated region rs61764370 T/G of KRAS leads to its higher expression;Genetic modulation of the Let 7 microRNA binding to KRAS 3' untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab irinotecan; There is increasing evidence that the Let-7 microRNA miRNA exerts an effect as a tumor suppressor by targeting the KRAS mRNA; The Let-7 complementary site LCS6 T>G variant in the KRAS 3'-untranslated region weakens Let-7 binding;A let 7 microRNA binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy;High let 7a microRNA levels in KRAS mutated colorectal carcinomas may rescue anti EGFR therapy effects in patients with chemotherapy refractory metastatic disease; Preclinical and experimental data in vivo indicate that Lethal-7 Let-7 microRNA downregulates KRAS with antitumor effects in the presence of activating KRAS mutations; In 59 patients harboring KRAS mutations Let-7a levels were analyzed for association with overall survival OS and progression-free survival PFS times; An exploratory subgroup analysis was performed using the rs61764370 LCS6 T>G polymorphism that experimentally impairs Let-7 binding to KRAS mRNA; In patients with KRAS mutations Let-7a analysis may serve to identify subgroups of patients who may still benefit from EGFR inhibition and this may open up new perspectives for alternative treatment strategies;A SNP in a let 7 microRNA complementary site in the KRAS 3' untranslated region increases non small cell lung cancer risk; The purpose of this study was to identify single nucleotide polymorphisms SNP that could modify let-7 binding and to assess the effect of such SNPs on target gene regulation and risk for non-small cell lung cancer NSCLC let-7 complementary sites LCS were sequenced in the KRAS 3' untranslated region from 74 NSCLC cases to identify mutations and SNPs that correlated with NSCLC; The LCS6 variant allele in a KRAS miRANA complementary site is significantly associated with increased risk for NSCLC among moderate smokers and represents a new paradigm for let-7 miRNAs in lung cancer susceptibility
37 hsa-miR-126-3p KRAS 0.05 0.73013 -0.04 0.6721 miRNAWalker2 validate; miRTarBase -0.12 0.00015 22845403 miR-126 is also known to target other crucial oncogenes in PDAC such as KRAS and CRK
38 hsa-miR-155-5p KRAS 0.53 0.00249 -0.04 0.6721 miRNAWalker2 validate; miRNATAP -0.11 1.0E-5 NA
39 hsa-miR-181a-5p KRAS 0.82 0 -0.04 0.6721 miRNAWalker2 validate -0.21 0 24098024; 27517749; 26124189 The KRAS mutational status was determined by pyrosequencing and miR-181a expression was measured by quantitative RT-PCR in CRC tumour tissue and corresponding non-neoplastic colon tissue;Here we report that miR-181a directly binds to 3'-untranslated regions UTRs; downregulates KRAS NRAS and MAPK1; and decreases AML growth; The delivery of miR-181a mimics to target AML cells using transferrin-targeting lipopolyplex nanoparticles NP increased mature miR-181a; downregulated KRAS NRAS and MAPK1; and resulted in decreased phosphorylation of the downstream RAS effectors;MiR 181a 5p inhibits cell proliferation and migration by targeting Kras in non small cell lung cancer A549 cells; Luciferase activity assay results demonstrated that two binding sites of Kras could be directly targeted by miR-181a-5p; Furthermore Kras was down-regulated by miR-181a-5p at both transcriptional and translational levels; SiRNA-mediated Kras down-regulation could mimic the effects of miR-181a-5p mimic in A549 cells; Our findings suggest that miR-181a-5p plays a potential role in tumor suppression by partially targeting Kras and has the potential therapeutic application in NSCLC patients
40 hsa-miR-186-5p KRAS 0.35 0.00015 -0.04 0.6721 mirMAP -0.21 1.0E-5 NA
41 hsa-miR-30a-5p KRAS -1.8 0 -0.04 0.6721 mirMAP; miRNATAP -0.11 1.0E-5 NA
42 hsa-miR-30b-5p KRAS -0.4 0.00347 -0.04 0.6721 mirMAP; miRNATAP -0.15 0 NA
43 hsa-miR-30c-5p KRAS 0.02 0.88637 -0.04 0.6721 mirMAP; miRNATAP -0.16 0 22701724 Deregulated miRNAs in hereditary breast cancer revealed a role for miR 30c in regulating KRAS oncogene; In particular we experimentally validated KRAS as a miR-30c target; Luciferase assays confirmed that miR-30c binds the 3'UTR of KRAS transcripts and expression of pre-miR-30c down-regulated KRAS mRNA and protein; In addition we provide evidence that KRAS is a target of miR-30c and that this miRNA suppresses breast cancer cell growth potentially through inhibition of KRAS signaling
44 hsa-miR-501-3p KRAS 0.82 0 -0.04 0.6721 MirTarget; PITA; TargetScan; miRNATAP -0.11 0.00026 NA
45 hsa-miR-542-3p KRAS 0.64 0 -0.04 0.6721 miRanda -0.14 3.0E-5 NA
46 hsa-miR-30c-5p MAP2K1 0.02 0.88637 0.14 0.05904 miRNAWalker2 validate -0.11 0 NA
47 hsa-miR-34a-5p MAP2K1 -0.12 0.364 0.14 0.05904 miRNAWalker2 validate; miRTarBase -0.12 0 NA
48 hsa-let-7b-5p MAP2K2 -0.25 0.02114 -0.14 0.11731 miRNAWalker2 validate -0.23 0 NA
49 hsa-miR-130a-3p MAPK1 0.67 0 -0.03 0.75566 mirMAP -0.12 0 NA
50 hsa-miR-140-5p MAPK1 -0.41 0.00014 -0.03 0.75566 miRanda -0.11 0.00107 NA
51 hsa-miR-16-2-3p MAPK1 1.16 0 -0.03 0.75566 mirMAP -0.12 0 NA
52 hsa-miR-19a-3p MAPK1 1.36 0 -0.03 0.75566 mirMAP -0.11 0 NA
53 hsa-miR-19b-3p MAPK1 0.54 0.00062 -0.03 0.75566 mirMAP -0.15 0 NA
54 hsa-miR-24-1-5p MAPK1 -0.05 0.74286 -0.03 0.75566 mirMAP -0.12 0 NA
55 hsa-miR-29a-5p MAPK1 0.32 0.03704 -0.03 0.75566 mirMAP -0.1 1.0E-5 NA
56 hsa-miR-29b-2-5p MAPK1 -0.5 0.00073 -0.03 0.75566 mirMAP -0.14 0 NA
57 hsa-miR-29b-3p MAPK1 -0.11 0.51126 -0.03 0.75566 mirMAP -0.16 0 NA
58 hsa-miR-30b-5p MAPK1 -0.4 0.00347 -0.03 0.75566 mirMAP -0.17 0 NA
59 hsa-miR-30c-5p MAPK1 0.02 0.88637 -0.03 0.75566 mirMAP -0.17 0 NA
60 hsa-miR-30d-3p MAPK1 -0.58 0 -0.03 0.75566 mirMAP -0.12 2.0E-5 NA
61 hsa-miR-32-5p MAPK1 -0.32 0.01025 -0.03 0.75566 mirMAP -0.12 3.0E-5 NA
62 hsa-miR-320a MAPK1 0.8 0 -0.03 0.75566 miRNAWalker2 validate; PITA; miRanda; miRNATAP -0.13 0 NA
63 hsa-miR-338-3p MAPK1 -0.95 0 -0.03 0.75566 miRanda -0.13 0 NA
64 hsa-miR-342-3p MAPK1 1 0 -0.03 0.75566 miRanda; mirMAP -0.17 0 NA
65 hsa-miR-34a-5p MAPK1 -0.12 0.364 -0.03 0.75566 mirMAP -0.23 0 NA
66 hsa-miR-362-3p MAPK1 -0.7 0 -0.03 0.75566 mirMAP -0.11 0 NA
67 hsa-miR-362-5p MAPK1 0.41 0.04043 -0.03 0.75566 mirMAP -0.14 0 NA
68 hsa-miR-374a-3p MAPK1 -0.3 0.00683 -0.03 0.75566 mirMAP -0.11 0.00057 NA
69 hsa-miR-374b-5p MAPK1 -0.29 0.00415 -0.03 0.75566 mirMAP -0.19 0 NA
70 hsa-miR-454-3p MAPK1 1.54 0 -0.03 0.75566 mirMAP -0.13 0 NA
71 hsa-miR-500a-3p MAPK1 0.46 0.00069 -0.03 0.75566 mirMAP -0.18 0 NA
72 hsa-miR-501-3p MAPK1 0.82 0 -0.03 0.75566 mirMAP -0.11 0 NA
73 hsa-miR-501-5p MAPK1 1.03 0 -0.03 0.75566 mirMAP -0.1 0 NA
74 hsa-miR-502-3p MAPK1 -0.17 0.10688 -0.03 0.75566 mirMAP -0.12 0.00064 NA
75 hsa-miR-505-3p MAPK1 0.91 0 -0.03 0.75566 mirMAP -0.11 4.0E-5 NA
76 hsa-miR-660-5p MAPK1 -0.2 0.10109 -0.03 0.75566 mirMAP -0.2 0 NA
77 hsa-let-7a-5p MAPK11 -0.44 3.0E-5 0.66 0 miRNAWalker2 validate -0.23 7.0E-5 NA
78 hsa-miR-140-3p MAPK11 -0.97 0 0.66 0 mirMAP -0.18 0.00205 NA
79 hsa-miR-125a-3p MAPK13 0.12 0.44483 -0.51 0.0007 miRanda -0.2 1.0E-5 NA
80 hsa-miR-320a MAPK14 0.8 0 -0.1 0.17305 PITA; miRanda -0.11 0 NA
81 hsa-miR-320b MAPK3 1.23 0 -0.86 0 miRNAWalker2 validate -0.15 0 NA
82 hsa-miR-34a-5p MAPK3 -0.12 0.364 -0.86 0 miRNAWalker2 validate -0.14 1.0E-5 NA
83 hsa-miR-423-3p MAPK3 1.2 0 -0.86 0 miRNAWalker2 validate -0.11 0.00069 NA
84 hsa-miR-423-5p MAPK3 0.6 0 -0.86 0 miRNATAP -0.16 0 NA
85 hsa-miR-542-3p MAPK3 0.64 0 -0.86 0 miRanda -0.11 0.00048 NA
86 hsa-miR-421 MAPKAPK3 0.95 0 -1.17 0 miRanda -0.11 0.0004 NA
87 hsa-miR-429 MAPKAPK3 0.56 0.00564 -1.17 0 miRNATAP -0.14 0 NA
88 hsa-miR-103a-3p NFAT5 0.56 0 -0.14 0.16169 MirTarget -0.21 2.0E-5 NA
89 hsa-miR-106b-5p NFAT5 0.5 1.0E-5 -0.14 0.16169 MirTarget; miRNATAP -0.15 0.00013 NA
90 hsa-miR-1301-3p NFAT5 2.14 0 -0.14 0.16169 MirTarget -0.13 0 NA
91 hsa-miR-130b-5p NFAT5 1.77 0 -0.14 0.16169 MirTarget; miRNATAP -0.1 9.0E-5 NA
92 hsa-miR-148b-5p NFAT5 1.15 0 -0.14 0.16169 MirTarget -0.12 1.0E-5 NA
93 hsa-miR-155-5p NFAT5 0.53 0.00249 -0.14 0.16169 mirMAP; miRNATAP -0.11 3.0E-5 NA
94 hsa-miR-15a-5p NFAT5 0.78 0 -0.14 0.16169 MirTarget -0.26 0 NA
95 hsa-miR-15b-5p NFAT5 0.85 0 -0.14 0.16169 MirTarget -0.18 0 NA
96 hsa-miR-16-1-3p NFAT5 0.96 0 -0.14 0.16169 mirMAP -0.15 0 NA
97 hsa-miR-16-5p NFAT5 0.52 0 -0.14 0.16169 MirTarget -0.15 0.00027 NA
98 hsa-miR-17-3p NFAT5 -0.01 0.90956 -0.14 0.16169 mirMAP -0.1 0.00945 NA
99 hsa-miR-17-5p NFAT5 1.42 0 -0.14 0.16169 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.11 2.0E-5 NA
100 hsa-miR-181a-5p NFAT5 0.82 0 -0.14 0.16169 MirTarget; miRNATAP -0.13 0.00092 NA
101 hsa-miR-181c-5p NFAT5 -0.17 0.19695 -0.14 0.16169 MirTarget; miRNATAP -0.11 0.0013 NA
102 hsa-miR-186-5p NFAT5 0.35 0.00015 -0.14 0.16169 MirTarget; mirMAP -0.15 0.00173 NA
103 hsa-miR-194-5p NFAT5 -0.02 0.87294 -0.14 0.16169 miRNATAP -0.14 2.0E-5 NA
104 hsa-miR-20a-5p NFAT5 1.15 0 -0.14 0.16169 MirTarget; miRNATAP -0.13 0 NA
105 hsa-miR-21-5p NFAT5 1.62 0 -0.14 0.16169 miRNAWalker2 validate; mirMAP -0.12 0.00238 NA
106 hsa-miR-25-3p NFAT5 0.77 0 -0.14 0.16169 miRNATAP -0.24 0 NA
107 hsa-miR-27b-5p NFAT5 0.58 0.00018 -0.14 0.16169 miRNATAP -0.1 0.00033 NA
108 hsa-miR-29b-3p NFAT5 -0.11 0.51126 -0.14 0.16169 MirTarget; miRNATAP -0.14 0 NA
109 hsa-miR-30b-5p NFAT5 -0.4 0.00347 -0.14 0.16169 MirTarget; miRNATAP -0.17 0 NA
110 hsa-miR-30c-5p NFAT5 0.02 0.88637 -0.14 0.16169 MirTarget; miRNATAP -0.16 0 NA
111 hsa-miR-32-5p NFAT5 -0.32 0.01025 -0.14 0.16169 miRNATAP -0.12 0.00106 NA
112 hsa-miR-320a NFAT5 0.8 0 -0.14 0.16169 mirMAP -0.13 4.0E-5 NA
113 hsa-miR-361-3p NFAT5 0.27 0.01479 -0.14 0.16169 MirTarget; PITA; miRNATAP -0.16 8.0E-5 NA
114 hsa-miR-3613-5p NFAT5 0.41 0.00535 -0.14 0.16169 miRNATAP -0.11 0.00029 NA
115 hsa-miR-362-5p NFAT5 0.41 0.04043 -0.14 0.16169 mirMAP -0.15 0 NA
116 hsa-miR-374a-3p NFAT5 -0.3 0.00683 -0.14 0.16169 mirMAP -0.2 0 NA
117 hsa-miR-374b-5p NFAT5 -0.29 0.00415 -0.14 0.16169 mirMAP; miRNATAP -0.21 0 NA
118 hsa-miR-500a-3p NFAT5 0.46 0.00069 -0.14 0.16169 MirTarget -0.2 0 NA
119 hsa-miR-500a-5p NFAT5 0.68 8.0E-5 -0.14 0.16169 mirMAP -0.11 4.0E-5 NA
120 hsa-miR-576-5p NFAT5 0.94 0 -0.14 0.16169 MirTarget; PITA; mirMAP -0.1 0.00152 NA
121 hsa-miR-582-3p NFAT5 -0.25 0.1438 -0.14 0.16169 MirTarget -0.1 0.00014 NA
122 hsa-miR-582-5p NFAT5 -0.04 0.82183 -0.14 0.16169 MirTarget; PITA; miRNATAP -0.11 9.0E-5 NA
123 hsa-miR-590-5p NFAT5 0.76 0 -0.14 0.16169 PITA; mirMAP; miRNATAP -0.12 0.00036 NA
124 hsa-miR-664a-3p NFAT5 -0.26 0.05132 -0.14 0.16169 MirTarget -0.13 0.00017 NA
125 hsa-miR-92a-3p NFAT5 0.99 0 -0.14 0.16169 miRNATAP -0.16 1.0E-5 NA
126 hsa-miR-93-5p NFAT5 1.61 0 -0.14 0.16169 MirTarget; miRNATAP -0.16 0 NA
127 hsa-miR-130b-5p NFATC2 1.77 0 -1.25 0.00017 MirTarget -0.51 0 NA
128 hsa-miR-16-2-3p NFATC2 1.16 0 -1.25 0.00017 mirMAP -0.66 0 NA
129 hsa-miR-182-5p NFATC2 1.15 0 -1.25 0.00017 mirMAP -0.55 0 NA
130 hsa-miR-186-5p NFATC2 0.35 0.00015 -1.25 0.00017 mirMAP -0.74 0 NA
131 hsa-miR-19a-3p NFATC2 1.36 0 -1.25 0.00017 mirMAP -0.92 0 NA
132 hsa-miR-19b-3p NFATC2 0.54 0.00062 -1.25 0.00017 mirMAP -1.16 0 NA
133 hsa-miR-205-3p NFATC2 1.3 0 -1.25 0.00017 mirMAP -0.34 0 NA
134 hsa-miR-222-3p NFATC2 1.08 0 -1.25 0.00017 MirTarget -0.48 0 NA
135 hsa-miR-2355-3p NFATC2 1.58 0 -1.25 0.00017 mirMAP -0.43 0 NA
136 hsa-miR-2355-5p NFATC2 1.47 0 -1.25 0.00017 MirTarget -0.59 0 NA
137 hsa-miR-26b-3p NFATC2 0.42 0.00223 -1.25 0.00017 MirTarget -0.32 0.00265 NA
138 hsa-miR-27b-5p NFATC2 0.58 0.00018 -1.25 0.00017 mirMAP -0.34 0.00034 NA
139 hsa-miR-29a-5p NFATC2 0.32 0.03704 -1.25 0.00017 mirMAP; miRNATAP -0.54 0 NA
140 hsa-miR-30b-5p NFATC2 -0.4 0.00347 -1.25 0.00017 MirTarget; mirMAP -0.76 0 NA
141 hsa-miR-30c-5p NFATC2 0.02 0.88637 -1.25 0.00017 MirTarget; mirMAP -0.82 0 NA
142 hsa-miR-31-3p NFATC2 2.1 0 -1.25 0.00017 MirTarget -0.15 0.00014 NA
143 hsa-miR-320a NFATC2 0.8 0 -1.25 0.00017 MirTarget -0.6 0 NA
144 hsa-miR-320b NFATC2 1.23 0 -1.25 0.00017 MirTarget -0.3 0.00059 NA
145 hsa-miR-335-3p NFATC2 0.34 0.05424 -1.25 0.00017 mirMAP -0.29 0.00042 NA
146 hsa-miR-33a-3p NFATC2 0.2 0.21234 -1.25 0.00017 mirMAP -0.25 0.00723 NA
147 hsa-miR-3607-3p NFATC2 1.01 9.0E-5 -1.25 0.00017 MirTarget; mirMAP -0.35 0 NA
148 hsa-miR-3613-5p NFATC2 0.41 0.00535 -1.25 0.00017 mirMAP -0.61 0 NA
149 hsa-miR-484 NFATC2 0.92 0 -1.25 0.00017 MirTarget -0.48 6.0E-5 NA
150 hsa-miR-7-1-3p NFATC2 1.14 0 -1.25 0.00017 mirMAP -0.44 1.0E-5 NA
NumGOOverlapSizeP ValueAdj. P Value
1 POSITIVE REGULATION OF RESPONSE TO STIMULUS 40 1929 1.052e-30 4.895e-27
2 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 38 1977 2.052e-27 4.775e-24
3 INTRACELLULAR SIGNAL TRANSDUCTION 35 1572 8.999e-27 1.396e-23
4 FC RECEPTOR SIGNALING PATHWAY 18 206 2.513e-23 2.923e-20
5 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 14 74 3.875e-23 3.606e-20
6 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 20 323 6.382e-23 4.949e-20
7 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 26 876 5.568e-22 3.701e-19
8 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 31 1656 7.604e-21 4.422e-18
9 FC EPSILON RECEPTOR SIGNALING PATHWAY 15 142 9.859e-21 5.097e-18
10 POSITIVE REGULATION OF CELL COMMUNICATION 30 1532 1.326e-20 5.61e-18
11 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 21 498 1.294e-20 5.61e-18
12 REGULATION OF IMMUNE SYSTEM PROCESS 29 1403 1.895e-20 7.346e-18
13 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 26 1036 3.751e-20 1.247e-17
14 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 26 1036 3.751e-20 1.247e-17
15 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 24 867 1.911e-19 5.928e-17
16 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 17 297 7.219e-19 2.099e-16
17 PHOSPHOLIPID METABOLIC PROCESS 18 364 7.673e-19 2.1e-16
18 REGULATION OF PHOSPHORUS METABOLIC PROCESS 29 1618 9.513e-19 2.459e-16
19 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 15 193 1.108e-18 2.713e-16
20 PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 9 23 2.078e-18 4.833e-16
21 POSITIVE REGULATION OF MAPK CASCADE 19 470 2.925e-18 6.481e-16
22 GLYCEROLIPID BIOSYNTHETIC PROCESS 15 211 4.293e-18 9.08e-16
23 POSITIVE REGULATION OF KINASE ACTIVITY 19 482 4.676e-18 9.459e-16
24 REGULATION OF KINASE ACTIVITY 22 776 6.056e-18 1.174e-15
25 PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 9 26 7.898e-18 1.47e-15
26 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 21 689 9.967e-18 1.784e-15
27 ACTIVATION OF IMMUNE RESPONSE 18 427 1.305e-17 2.25e-15
28 GLYCEROLIPID METABOLIC PROCESS 17 356 1.54e-17 2.559e-15
29 PHOSPHOLIPID BIOSYNTHETIC PROCESS 15 235 2.185e-17 3.505e-15
30 REGULATION OF IMMUNE RESPONSE 22 858 5.028e-17 7.799e-15
31 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 24 1135 9.074e-17 1.362e-14
32 CELLULAR LIPID METABOLIC PROCESS 22 913 1.847e-16 2.686e-14
33 IMMUNE SYSTEM PROCESS 29 1984 2.365e-16 3.335e-14
34 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 26 1492 2.962e-16 4.053e-14
35 REGULATION OF TRANSFERASE ACTIVITY 22 946 3.874e-16 5.15e-14
36 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 19 616 4.313e-16 5.574e-14
37 PHOSPHORYLATION 24 1228 5.362e-16 6.744e-14
38 FC GAMMA RECEPTOR SIGNALING PATHWAY 11 95 7.869e-16 9.635e-14
39 LOCOMOTION 23 1114 8.55e-16 1.02e-13
40 REGULATION OF MAPK CASCADE 19 660 1.519e-15 1.723e-13
41 VASCULATURE DEVELOPMENT 17 469 1.518e-15 1.723e-13
42 PLATELET ACTIVATION 12 142 1.656e-15 1.792e-13
43 POSITIVE REGULATION OF IMMUNE RESPONSE 18 563 1.654e-15 1.792e-13
44 POSITIVE REGULATION OF MOLECULAR FUNCTION 27 1791 2.195e-15 2.321e-13
45 POSITIVE REGULATION OF MAP KINASE ACTIVITY 13 207 4.768e-15 4.93e-13
46 PROTEIN PHOSPHORYLATION 21 944 5.452e-15 5.515e-13
47 PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 7 16 5.927e-15 5.867e-13
48 PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 8 31 8.951e-15 8.677e-13
49 PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 7 17 1.006e-14 9.357e-13
50 PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 7 17 1.006e-14 9.357e-13
51 LIPID BIOSYNTHETIC PROCESS 17 539 1.491e-14 1.361e-12
52 LIPID METABOLIC PROCESS 22 1158 2.518e-14 2.253e-12
53 REGULATION OF TRANSPORT 26 1804 2.808e-14 2.466e-12
54 REGULATION OF RESPONSE TO STRESS 24 1468 2.863e-14 2.467e-12
55 CELL ACTIVATION 17 568 3.507e-14 2.967e-12
56 CARDIOVASCULAR SYSTEM DEVELOPMENT 19 788 3.738e-14 3.051e-12
57 CIRCULATORY SYSTEM DEVELOPMENT 19 788 3.738e-14 3.051e-12
58 REGULATION OF MAP KINASE ACTIVITY 14 319 5.321e-14 4.269e-12
59 PHOSPHATIDYLCHOLINE METABOLIC PROCESS 9 64 6.466e-14 5.1e-12
60 REGULATION OF PROTEIN MODIFICATION PROCESS 25 1710 8.269e-14 6.412e-12
61 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 20 957 9.571e-14 7.3e-12
62 POSITIVE REGULATION OF LOCOMOTION 15 420 1.172e-13 8.799e-12
63 ORGANOPHOSPHATE METABOLIC PROCESS 19 885 2.968e-13 2.192e-11
64 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 15 450 3.184e-13 2.315e-11
65 RESPONSE TO EXTERNAL STIMULUS 25 1821 3.442e-13 2.464e-11
66 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 13 289 3.51e-13 2.475e-11
67 ANGIOGENESIS 13 293 4.182e-13 2.904e-11
68 ERBB SIGNALING PATHWAY 9 79 4.694e-13 3.212e-11
69 TAXIS 15 464 4.953e-13 3.34e-11
70 PHOSPHATIDYLSERINE METABOLIC PROCESS 7 28 5.991e-13 3.982e-11
71 POSITIVE REGULATION OF CATALYTIC ACTIVITY 23 1518 6.165e-13 4.04e-11
72 HEMOSTASIS 13 311 8.924e-13 5.767e-11
73 ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 9 85 9.281e-13 5.916e-11
74 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 22 1395 1.092e-12 6.866e-11
75 LIPID CATABOLIC PROCESS 12 247 1.284e-12 7.969e-11
76 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 55 1.318e-12 8.069e-11
77 REGULATION OF BODY FLUID LEVELS 15 506 1.719e-12 1.039e-10
78 PHAGOCYTOSIS 11 190 1.83e-12 1.092e-10
79 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 21 1275 1.903e-12 1.121e-10
80 LEUKOCYTE MIGRATION 12 259 2.248e-12 1.307e-10
81 ALDITOL PHOSPHATE METABOLIC PROCESS 7 35 3.356e-12 1.928e-10
82 BLOOD VESSEL MORPHOGENESIS 13 364 6.501e-12 3.689e-10
83 WOUND HEALING 14 470 1.011e-11 5.602e-10
84 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 14 470 1.011e-11 5.602e-10
85 IMMUNE EFFECTOR PROCESS 14 486 1.58e-11 8.649e-10
86 AMMONIUM ION METABOLIC PROCESS 10 169 1.654e-11 8.893e-10
87 CELL MOTILITY 17 835 1.682e-11 8.893e-10
88 LOCALIZATION OF CELL 17 835 1.682e-11 8.893e-10
89 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 23 1805 2.207e-11 1.154e-09
90 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 13 404 2.394e-11 1.238e-09
91 ENDOCYTOSIS 14 509 2.921e-11 1.493e-09
92 AMINE METABOLIC PROCESS 9 131 4.874e-11 2.465e-09
93 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 10 195 6.828e-11 3.416e-09
94 ALCOHOL METABOLIC PROCESS 12 348 7.047e-11 3.488e-09
95 CALCIUM MEDIATED SIGNALING 8 90 7.834e-11 3.827e-09
96 RESPONSE TO OXYGEN CONTAINING COMPOUND 20 1381 7.895e-11 3.827e-09
97 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 16 799 9.778e-11 4.69e-09
98 RESPONSE TO WOUNDING 14 563 1.106e-10 5.249e-09
99 ACTIVATION OF PROTEIN KINASE ACTIVITY 11 279 1.164e-10 5.47e-09
100 PEPTIDYL SERINE MODIFICATION 9 148 1.461e-10 6.799e-09
101 IMMUNE SYSTEM DEVELOPMENT 14 582 1.709e-10 7.874e-09
102 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 10 216 1.866e-10 8.514e-09
103 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 11 296 2.185e-10 9.871e-09
104 PHOSPHATIDIC ACID METABOLIC PROCESS 6 33 2.407e-10 1.077e-08
105 REGULATION OF CELL DEATH 20 1472 2.461e-10 1.08e-08
106 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 18 1142 2.44e-10 1.08e-08
107 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 18 1152 2.81e-10 1.222e-08
108 SECOND MESSENGER MEDIATED SIGNALING 9 160 2.934e-10 1.264e-08
109 REGULATION OF CELL DIFFERENTIATION 20 1492 3.125e-10 1.334e-08
110 REGULATION OF CELL PROLIFERATION 20 1496 3.277e-10 1.386e-08
111 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 17 1021 3.842e-10 1.611e-08
112 REGULATION OF INTRACELLULAR TRANSPORT 14 621 3.987e-10 1.657e-08
113 REGULATION OF CELL ADHESION 14 629 4.71e-10 1.939e-08
114 REGULATION OF CELLULAR COMPONENT MOVEMENT 15 771 6.389e-10 2.608e-08
115 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 8 120 8.007e-10 3.24e-08
116 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 6 40 8.227e-10 3.3e-08
117 VESICLE MEDIATED TRANSPORT 18 1239 9.074e-10 3.609e-08
118 POSITIVE REGULATION OF TRANSPORT 16 936 9.885e-10 3.898e-08
119 REGULATION OF HOMEOSTATIC PROCESS 12 447 1.232e-09 4.819e-08
120 POSITIVE REGULATION OF CELL PROLIFERATION 15 814 1.345e-09 5.215e-08
121 SINGLE ORGANISM CATABOLIC PROCESS 16 957 1.362e-09 5.239e-08
122 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 5 20 1.468e-09 5.563e-08
123 REGULATION OF CELLULAR LOCALIZATION 18 1277 1.471e-09 5.563e-08
124 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 8 133 1.82e-09 6.829e-08
125 POSITIVE REGULATION OF DEFENSE RESPONSE 11 364 1.935e-09 7.202e-08
126 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 20 1672 2.302e-09 8.439e-08
127 ACTIVATION OF MAPK ACTIVITY 8 137 2.303e-09 8.439e-08
128 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 8 138 2.44e-09 8.871e-08
129 REGULATION OF LIPID METABOLIC PROCESS 10 282 2.486e-09 8.968e-08
130 REGULATION OF LIPID KINASE ACTIVITY 6 48 2.589e-09 9.266e-08
131 RESPONSE TO NITROGEN COMPOUND 15 859 2.8e-09 9.928e-08
132 REGULATION OF CYTOPLASMIC TRANSPORT 12 481 2.816e-09 9.928e-08
133 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 12 482 2.883e-09 1.009e-07
134 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 6 49 2.944e-09 1.022e-07
135 T CELL RECEPTOR SIGNALING PATHWAY 8 146 3.815e-09 1.315e-07
136 POSITIVE REGULATION OF GENE EXPRESSION 20 1733 4.281e-09 1.465e-07
137 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 4.981e-09 1.68e-07
138 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 5 25 4.981e-09 1.68e-07
139 LIPID PHOSPHORYLATION 7 99 6.548e-09 2.192e-07
140 REGULATION OF RESPONSE TO WOUNDING 11 413 7.2e-09 2.393e-07
141 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 15 926 7.725e-09 2.549e-07
142 RESPONSE TO ENDOGENOUS STIMULUS 18 1450 1.092e-08 3.58e-07
143 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 6 61 1.142e-08 3.715e-07
144 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 20 1848 1.288e-08 4.163e-07
145 RESPONSE TO GROWTH HORMONE 5 30 1.323e-08 4.246e-07
146 REGULATION OF CELL SUBSTRATE ADHESION 8 173 1.45e-08 4.621e-07
147 POSITIVE REGULATION OF CELL DIFFERENTIATION 14 823 1.475e-08 4.668e-07
148 REGULATION OF ENDOTHELIAL CELL MIGRATION 7 114 1.757e-08 5.524e-07
149 REGULATION OF GOLGI ORGANIZATION 4 12 1.98e-08 6.142e-07
150 TRACHEA MORPHOGENESIS 4 12 1.98e-08 6.142e-07
151 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 6 67 2.028e-08 6.249e-07
152 REGULATION OF VESICLE MEDIATED TRANSPORT 11 462 2.283e-08 6.99e-07
153 SINGLE ORGANISM BIOSYNTHETIC PROCESS 17 1340 2.317e-08 7.045e-07
154 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 10 360 2.547e-08 7.696e-07
155 RESPONSE TO ABIOTIC STIMULUS 15 1024 2.959e-08 8.883e-07
156 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 10 370 3.297e-08 9.834e-07
157 REGULATION OF CELL ACTIVATION 11 484 3.672e-08 1.088e-06
158 RESPONSE TO BIOTIC STIMULUS 14 886 3.719e-08 1.095e-06
159 SMALL MOLECULE METABOLIC PROCESS 19 1767 3.828e-08 1.12e-06
160 REGULATION OF CELL CELL ADHESION 10 380 4.236e-08 1.232e-06
161 REGULATION OF DEFENSE RESPONSE 13 759 4.939e-08 1.427e-06
162 ERBB2 SIGNALING PATHWAY 5 39 5.252e-08 1.509e-06
163 NEURON PROJECTION GUIDANCE 8 205 5.433e-08 1.551e-06
164 LIPID MODIFICATION 8 210 6.545e-08 1.857e-06
165 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 11 514 6.765e-08 1.908e-06
166 REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 4 16 7.224e-08 2.025e-06
167 MODULATION OF SYNAPTIC TRANSMISSION 9 301 7.333e-08 2.043e-06
168 REGULATION OF HOMOTYPIC CELL CELL ADHESION 9 307 8.677e-08 2.403e-06
169 RESPONSE TO BACTERIUM 11 528 8.877e-08 2.444e-06
170 LUNG MORPHOGENESIS 5 45 1.101e-07 3.015e-06
171 REGULATION OF CELL MATRIX ADHESION 6 90 1.209e-07 3.273e-06
172 INOSITOL PHOSPHATE MEDIATED SIGNALING 4 18 1.21e-07 3.273e-06
173 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 9 321 1.268e-07 3.41e-06
174 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 8 232 1.409e-07 3.768e-06
175 REGULATION OF VASCULATURE DEVELOPMENT 8 233 1.456e-07 3.872e-06
176 HOMEOSTATIC PROCESS 16 1337 1.514e-07 4.001e-06
177 REGULATION OF CELL PROJECTION ORGANIZATION 11 558 1.548e-07 4.069e-06
178 ICOSANOID METABOLIC PROCESS 6 96 1.779e-07 4.624e-06
179 FATTY ACID DERIVATIVE METABOLIC PROCESS 6 96 1.779e-07 4.624e-06
180 REGULATION OF ORGANELLE ORGANIZATION 15 1178 1.855e-07 4.795e-06
181 TRACHEA DEVELOPMENT 4 20 1.908e-07 4.906e-06
182 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 51 2.093e-07 5.322e-06
183 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 51 2.093e-07 5.322e-06
184 CELLULAR RESPONSE TO STRESS 17 1565 2.214e-07 5.6e-06
185 REGULATION OF EPITHELIAL CELL MIGRATION 7 166 2.336e-07 5.875e-06
186 NEGATIVE REGULATION OF CELL DEATH 13 872 2.463e-07 6.16e-06
187 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 6 103 2.706e-07 6.733e-06
188 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 9 352 2.764e-07 6.84e-06
189 B CELL RECEPTOR SIGNALING PATHWAY 5 54 2.801e-07 6.897e-06
190 POSITIVE REGULATION OF PROTEIN IMPORT 6 104 2.866e-07 6.993e-06
191 ERK1 AND ERK2 CASCADE 4 22 2.87e-07 6.993e-06
192 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 7 172 2.973e-07 7.206e-06
193 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 258 3.17e-07 7.644e-06
194 RESPONSE TO HORMONE 13 893 3.233e-07 7.754e-06
195 CELLULAR RESPONSE TO ABIOTIC STIMULUS 8 263 3.668e-07 8.753e-06
196 ENDOTHELIAL CELL MIGRATION 5 57 3.687e-07 8.753e-06
197 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 9 365 3.748e-07 8.852e-06
198 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 9 368 4.014e-07 9.433e-06
199 THYROID GLAND DEVELOPMENT 4 25 4.935e-07 1.154e-05
200 CELLULAR RESPONSE TO NITROGEN COMPOUND 10 505 5.887e-07 1.37e-05
201 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 8 282 6.219e-07 1.44e-05
202 REGULATION OF PROTEIN LOCALIZATION 13 950 6.528e-07 1.504e-05
203 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 10 513 6.792e-07 1.557e-05
204 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 6 121 7.02e-07 1.601e-05
205 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 7 197 7.434e-07 1.679e-05
206 RESPIRATORY SYSTEM DEVELOPMENT 7 197 7.434e-07 1.679e-05
207 LEUKOCYTE DIFFERENTIATION 8 292 8.086e-07 1.814e-05
208 INOSITOL LIPID MEDIATED SIGNALING 6 124 8.108e-07 1.814e-05
209 NEURON PROJECTION MORPHOGENESIS 9 402 8.39e-07 1.868e-05
210 REGULATION OF VACUOLAR TRANSPORT 4 29 9.195e-07 2.037e-05
211 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 6 128 9.77e-07 2.155e-05
212 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 6 129 1.023e-06 2.245e-05
213 PHOSPHOLIPID CATABOLIC PROCESS 4 30 1.059e-06 2.313e-05
214 LEUKOCYTE ACTIVATION 9 414 1.071e-06 2.317e-05
215 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 8 303 1.067e-06 2.317e-05
216 CELL DEATH 13 1001 1.176e-06 2.533e-05
217 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 4 31 1.214e-06 2.602e-05
218 PEPTIDYL AMINO ACID MODIFICATION 12 841 1.235e-06 2.636e-05
219 REGULATION OF CELLULAR PROTEIN LOCALIZATION 10 552 1.319e-06 2.801e-05
220 PLACENTA DEVELOPMENT 6 138 1.518e-06 3.21e-05
221 CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS 7 220 1.556e-06 3.277e-05
222 REGULATION OF CYTOKINE PRODUCTION 10 563 1.575e-06 3.301e-05
223 REGULATION OF SYNAPTIC PLASTICITY 6 140 1.651e-06 3.444e-05
224 NEUROGENESIS 15 1402 1.701e-06 3.534e-05
225 ORGAN FORMATION 4 34 1.778e-06 3.678e-05
226 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 10 573 1.844e-06 3.797e-05
227 RAS PROTEIN SIGNAL TRANSDUCTION 6 143 1.868e-06 3.828e-05
228 CELL DEVELOPMENT 15 1426 2.103e-06 4.291e-05
229 RESPONSE TO LIPID 12 888 2.178e-06 4.426e-05
230 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 8 337 2.36e-06 4.774e-05
231 SINGLE ORGANISM CELL ADHESION 9 459 2.503e-06 5.021e-05
232 CELLULAR COMPONENT MORPHOGENESIS 12 900 2.503e-06 5.021e-05
233 CELL PROJECTION ORGANIZATION 12 902 2.562e-06 5.116e-05
234 TISSUE MIGRATION 5 84 2.579e-06 5.127e-05
235 LYMPHOCYTE ACTIVATION 8 342 2.632e-06 5.19e-05
236 REGULATION OF ERK1 AND ERK2 CASCADE 7 238 2.624e-06 5.19e-05
237 HEART DEVELOPMENT 9 466 2.833e-06 5.561e-05
238 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 6 154 2.873e-06 5.617e-05
239 POSITIVE REGULATION OF DNA REPLICATION 5 86 2.897e-06 5.641e-05
240 ASTROCYTE DIFFERENTIATION 4 39 3.124e-06 6.056e-05
241 RESPONSE TO GROWTH FACTOR 9 475 3.311e-06 6.392e-05
242 EPITHELIAL CELL PROLIFERATION 5 89 3.433e-06 6.601e-05
243 POSITIVE REGULATION OF RESPONSE TO WOUNDING 6 162 3.851e-06 7.374e-05
244 REGULATION OF PEPTIDE TRANSPORT 7 256 4.245e-06 8.096e-05
245 CELL PART MORPHOGENESIS 10 633 4.477e-06 8.502e-05
246 TISSUE DEVELOPMENT 15 1518 4.555e-06 8.615e-05
247 POSITIVE REGULATION OF CYTOKINE PRODUCTION 8 370 4.704e-06 8.862e-05
248 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 95 4.736e-06 8.875e-05
249 RESPONSE TO CARBOHYDRATE 6 168 4.749e-06 8.875e-05
250 POSITIVE REGULATION OF CELL ADHESION 8 376 5.294e-06 9.853e-05
251 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 381 5.832e-06 0.0001081
252 ICOSANOID BIOSYNTHETIC PROCESS 4 46 6.115e-06 0.0001125
253 FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 4 46 6.115e-06 0.0001125
254 CATABOLIC PROCESS 16 1773 6.435e-06 0.0001179
255 CELLULAR RESPONSE TO PEPTIDE 7 274 6.628e-06 0.0001209
256 THYMUS DEVELOPMENT 4 47 6.671e-06 0.0001213
257 CELL PROLIFERATION 10 672 7.576e-06 0.0001372
258 REGULATION OF PROTEIN IMPORT 6 183 7.76e-06 0.00014
259 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 12 1008 7.999e-06 0.0001437
260 REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 50 8.564e-06 0.0001515
261 ORGAN MORPHOGENESIS 11 841 8.467e-06 0.0001515
262 FACE DEVELOPMENT 4 50 8.564e-06 0.0001515
263 ARACHIDONIC ACID METABOLIC PROCESS 4 50 8.564e-06 0.0001515
264 RESPONSE TO PEPTIDE 8 404 8.945e-06 0.0001577
265 UNSATURATED FATTY ACID METABOLIC PROCESS 5 109 9.292e-06 0.0001632
266 REPRODUCTIVE SYSTEM DEVELOPMENT 8 408 9.61e-06 0.0001681
267 REGULATION OF CELLULAR RESPONSE TO STRESS 10 691 9.666e-06 0.0001685
268 NEURON PROJECTION DEVELOPMENT 9 545 1.004e-05 0.0001744
269 PROTEIN AUTOPHOSPHORYLATION 6 192 1.021e-05 0.0001766
270 FATTY ACID METABOLIC PROCESS 7 296 1.096e-05 0.0001889
271 REGULATION OF MUSCLE SYSTEM PROCESS 6 195 1.115e-05 0.0001901
272 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 5 113 1.108e-05 0.0001901
273 REGULATION OF CELL MORPHOGENESIS 9 552 1.112e-05 0.0001901
274 CHEMICAL HOMEOSTASIS 11 874 1.216e-05 0.0002058
275 NEURON DIFFERENTIATION 11 874 1.216e-05 0.0002058
276 RESPONSE TO CYTOKINE 10 714 1.285e-05 0.0002166
277 OVULATION 3 18 1.316e-05 0.0002203
278 MAST CELL MEDIATED IMMUNITY 3 18 1.316e-05 0.0002203
279 REGULATION OF PROTEIN TARGETING 7 307 1.388e-05 0.0002315
280 CYTOKINE PRODUCTION 5 120 1.483e-05 0.0002465
281 REGULATION OF CALCIUM ION TRANSPORT 6 209 1.653e-05 0.0002737
282 POSITIVE REGULATION OF CYCLASE ACTIVITY 4 61 1.9e-05 0.0003135
283 INFLAMMATORY RESPONSE 8 454 2.077e-05 0.0003415
284 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 6 218 2.098e-05 0.0003437
285 MAST CELL ACTIVATION 3 21 2.133e-05 0.000347
286 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 21 2.133e-05 0.000347
287 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 6 220 2.208e-05 0.0003574
288 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 9 602 2.212e-05 0.0003574
289 RESPONSE TO METAL ION 7 333 2.342e-05 0.000377
290 REGULATION OF CELLULAR COMPONENT BIOGENESIS 10 767 2.382e-05 0.0003821
291 CELLULAR RESPONSE TO VIRUS 3 22 2.465e-05 0.0003942
292 CELLULAR RESPONSE TO UV 4 66 2.599e-05 0.0004142
293 CELLULAR RESPONSE TO RADIATION 5 137 2.813e-05 0.0004467
294 LYSOSOME LOCALIZATION 3 23 2.83e-05 0.0004479
295 REGULATION OF CELL JUNCTION ASSEMBLY 4 68 2.926e-05 0.0004615
296 RESPONSE TO INORGANIC SUBSTANCE 8 479 3.046e-05 0.0004788
297 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 3 24 3.228e-05 0.0005058
298 MUSCLE CELL DIFFERENTIATION 6 237 3.354e-05 0.0005238
299 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 4 71 3.471e-05 0.0005401
300 RESPONSE TO TOXIC SUBSTANCE 6 241 3.684e-05 0.0005713
301 POSITIVE REGULATION OF AUTOPHAGY 4 75 4.308e-05 0.000666
302 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 11 1004 4.382e-05 0.0006751
303 CELLULAR LIPID CATABOLIC PROCESS 5 151 4.482e-05 0.0006883
304 INTRINSIC APOPTOTIC SIGNALING PATHWAY 5 152 4.626e-05 0.0007078
305 RESPONSE TO LITHIUM ION 3 27 4.64e-05 0.0007078
306 REGULATION OF NEURON DEATH 6 252 4.724e-05 0.0007184
307 AMEBOIDAL TYPE CELL MIGRATION 5 154 4.923e-05 0.0007462
308 REGULATION OF CELL DEVELOPMENT 10 836 4.949e-05 0.0007477
309 LYMPHOCYTE COSTIMULATION 4 78 5.027e-05 0.0007545
310 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 4 78 5.027e-05 0.0007545
311 LEUKOCYTE CELL CELL ADHESION 6 255 5.046e-05 0.0007549
312 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 3 28 5.187e-05 0.0007736
313 CELLULAR HOMEOSTASIS 9 676 5.466e-05 0.0008126
314 CELLULAR RESPONSE TO MECHANICAL STIMULUS 4 80 5.553e-05 0.0008228
315 BIOLOGICAL ADHESION 11 1032 5.624e-05 0.0008308
316 POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 3 29 5.775e-05 0.0008503
317 DEFENSE RESPONSE 12 1231 5.806e-05 0.0008523
318 REGULATION OF DNA REPLICATION 5 161 6.082e-05 0.00089
319 NEURON DEVELOPMENT 9 687 6.191e-05 0.000903
320 REGULATION OF PROTEIN SECRETION 7 389 6.28e-05 0.0009103
321 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 5 162 6.264e-05 0.0009103
322 LEUKOCYTE DEGRANULATION 3 30 6.405e-05 0.0009198
323 RESPONSE TO EPIDERMAL GROWTH FACTOR 3 30 6.405e-05 0.0009198
324 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 3 30 6.405e-05 0.0009198
325 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 4 84 6.722e-05 0.0009624
326 GLAND DEVELOPMENT 7 395 6.914e-05 0.0009868
327 EPHRIN RECEPTOR SIGNALING PATHWAY 4 85 7.041e-05 0.001002
328 REGULATION OF SECRETION 9 699 7.072e-05 0.001003
329 MULTICELLULAR ORGANISMAL HOMEOSTASIS 6 272 7.213e-05 0.00102
330 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 3 32 7.796e-05 0.001099
331 HEAD DEVELOPMENT 9 709 7.886e-05 0.001109
332 LONG CHAIN FATTY ACID METABOLIC PROCESS 4 88 8.062e-05 0.00113
333 TISSUE HOMEOSTASIS 5 171 8.092e-05 0.001131
334 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 7 406 8.211e-05 0.001144
335 CELLULAR RESPONSE TO HORMONE STIMULUS 8 552 8.266e-05 0.001145
336 TUBE DEVELOPMENT 8 552 8.266e-05 0.001145
337 REGULATION OF NEURON DIFFERENTIATION 8 554 8.477e-05 0.001167
338 REGULATION OF NEURON PROJECTION DEVELOPMENT 7 408 8.467e-05 0.001167
339 STRIATED MUSCLE CELL DIFFERENTIATION 5 173 8.549e-05 0.001171
340 CELLULAR SENESCENCE 3 33 8.56e-05 0.001171
341 EMBRYO DEVELOPMENT 10 894 8.672e-05 0.001183
342 SINGLE ORGANISM CELLULAR LOCALIZATION 10 898 8.999e-05 0.001224
343 CELLULAR RESPONSE TO LIGHT STIMULUS 4 91 9.187e-05 0.001246
344 RESPONSE TO CORTICOSTEROID 5 176 9.271e-05 0.001254
345 REGULATION OF EPITHELIAL CELL PROLIFERATION 6 285 9.327e-05 0.001258
346 REPRODUCTION 12 1297 9.594e-05 0.00129
347 APOPTOTIC SIGNALING PATHWAY 6 289 0.0001007 0.00135
348 CELLULAR CHEMICAL HOMEOSTASIS 8 570 0.0001033 0.001381
349 RESPONSE TO ORGANIC CYCLIC COMPOUND 10 917 0.000107 0.001427
350 REGULATION OF INFLAMMATORY RESPONSE 6 294 0.0001106 0.00147
351 MYELOID LEUKOCYTE DIFFERENTIATION 4 96 0.0001131 0.001499
352 POSITIVE REGULATION OF DNA METABOLIC PROCESS 5 185 0.0001172 0.001549
353 PEPTIDYL TYROSINE MODIFICATION 5 186 0.0001202 0.001585
354 MYELOID LEUKOCYTE MIGRATION 4 99 0.0001274 0.00167
355 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 4 99 0.0001274 0.00167
356 MYELOID CELL DIFFERENTIATION 5 189 0.0001296 0.001694
357 REGULATION OF GLUCOSE TRANSPORT 4 100 0.0001325 0.001727
358 RESPONSE TO REACTIVE OXYGEN SPECIES 5 191 0.0001361 0.001769
359 REGULATION OF NEURON APOPTOTIC PROCESS 5 192 0.0001395 0.001808
360 ORGANONITROGEN COMPOUND METABOLIC PROCESS 14 1796 0.0001416 0.001823
361 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 3 39 0.0001418 0.001823
362 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 3 39 0.0001418 0.001823
363 POSITIVE REGULATION OF CELL ACTIVATION 6 311 0.0001503 0.001926
364 POSITIVE REGULATION OF CELL MATRIX ADHESION 3 40 0.000153 0.001956
365 POSITIVE REGULATION OF CELL DEATH 8 605 0.0001557 0.001985
366 CELL CELL ADHESION 8 608 0.000161 0.002047
367 MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 3 41 0.0001648 0.002089
368 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 4 106 0.0001659 0.002098
369 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 3 42 0.0001772 0.002228
370 POSITIVE REGULATION OF GLUCOSE TRANSPORT 3 42 0.0001772 0.002228
371 ACTIVATION OF INNATE IMMUNE RESPONSE 5 204 0.0001851 0.002321
372 REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 3 43 0.0001901 0.002371
373 MYELOID LEUKOCYTE MEDIATED IMMUNITY 3 43 0.0001901 0.002371
374 REGULATION OF METAL ION TRANSPORT 6 325 0.0001908 0.002374
375 ALCOHOL BIOSYNTHETIC PROCESS 4 111 0.0001981 0.002459
376 REGULATION OF PEPTIDE SECRETION 5 209 0.0002071 0.002556
377 LYMPHOCYTE DIFFERENTIATION 5 209 0.0002071 0.002556
378 POSITIVE REGULATION OF CELL DEVELOPMENT 7 472 0.0002083 0.002564
379 ORGANOPHOSPHATE CATABOLIC PROCESS 4 113 0.0002122 0.002598
380 RESPONSE TO MECHANICAL STIMULUS 5 210 0.0002118 0.002598
381 POSITIVE REGULATION OF PROTEIN SECRETION 5 211 0.0002165 0.002644
382 SPROUTING ANGIOGENESIS 3 45 0.0002178 0.002653
383 ESTABLISHMENT OF PROTEIN LOCALIZATION 12 1423 0.0002298 0.002792
384 PEPTIDYL THREONINE MODIFICATION 3 46 0.0002325 0.002803
385 INTRASPECIES INTERACTION BETWEEN ORGANISMS 3 46 0.0002325 0.002803
386 SOCIAL BEHAVIOR 3 46 0.0002325 0.002803
387 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 4 116 0.0002346 0.002821
388 LEUKOCYTE CHEMOTAXIS 4 117 0.0002425 0.002908
389 REGULATION OF DNA METABOLIC PROCESS 6 340 0.0002433 0.00291
390 POSITIVE REGULATION OF CHEMOTAXIS 4 120 0.0002671 0.003187
391 ESTABLISHMENT OF LOCALIZATION IN CELL 13 1676 0.0002731 0.00325
392 RESPONSE TO STEROID HORMONE 7 497 0.0002852 0.003379
393 REGULATED EXOCYTOSIS 5 224 0.0002854 0.003379
394 ENDOCRINE SYSTEM DEVELOPMENT 4 123 0.0002935 0.003458
395 RESPONSE TO OXIDATIVE STRESS 6 352 0.000293 0.003458
396 REGULATION OF CYTOSKELETON ORGANIZATION 7 502 0.000303 0.00356
397 MONOCARBOXYLIC ACID METABOLIC PROCESS 7 503 0.0003067 0.003585
398 NUCLEAR TRANSPORT 6 355 0.0003066 0.003585
399 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 5 228 0.0003096 0.00361
400 RESPONSE TO UV 4 126 0.0003218 0.003734
401 REGULATION OF SYSTEM PROCESS 7 507 0.0003217 0.003734
402 ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 6 361 0.0003353 0.003881
403 MUSCLE CELL DEVELOPMENT 4 128 0.0003416 0.003945
404 NUCLEAR IMPORT 4 129 0.0003519 0.004053
405 REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 3 53 0.0003543 0.00407
406 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 2 11 0.0003592 0.004077
407 CHEMICAL HOMEOSTASIS WITHIN A TISSUE 2 11 0.0003592 0.004077
408 REGULATION OF FEVER GENERATION 2 11 0.0003592 0.004077
409 CYCLOOXYGENASE PATHWAY 2 11 0.0003592 0.004077
410 POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 2 11 0.0003592 0.004077
411 CIRCULATORY SYSTEM PROCESS 6 366 0.0003608 0.004085
412 CENTRAL NERVOUS SYSTEM DEVELOPMENT 9 872 0.0003717 0.004198
413 POSITIVE REGULATION OF SECRETION 6 370 0.0003823 0.004307
414 B CELL ACTIVATION 4 132 0.000384 0.004316
415 POSITIVE REGULATION OF CELL CELL ADHESION 5 243 0.0004146 0.004648
416 REGULATION OF BROWN FAT CELL DIFFERENTIATION 2 12 0.0004304 0.004791
417 GLIAL CELL DIFFERENTIATION 4 136 0.00043 0.004791
418 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 2 12 0.0004304 0.004791
419 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 5 246 0.0004385 0.004869
420 UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 3 58 0.0004624 0.005123
421 RESPONSE TO ORGANOPHOSPHORUS 4 139 0.000467 0.005149
422 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 4 139 0.000467 0.005149
423 NON CANONICAL WNT SIGNALING PATHWAY 4 140 0.0004798 0.005278
424 VASCULOGENESIS 3 59 0.0004863 0.005324
425 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 3 59 0.0004863 0.005324
426 SYSTEM PROCESS 13 1785 0.0005036 0.005488
427 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 8 720 0.0005026 0.005488
428 LIPOXYGENASE PATHWAY 2 13 0.0005078 0.005507
429 LYMPH VESSEL MORPHOGENESIS 2 13 0.0005078 0.005507
430 REGULATION OF GLUCOSE IMPORT 3 60 0.0005109 0.005516
431 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 3 60 0.0005109 0.005516
432 REGULATION OF RESPIRATORY BURST 2 14 0.0005914 0.006198
433 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 2 14 0.0005914 0.006198
434 ARACHIDONIC ACID SECRETION 2 14 0.0005914 0.006198
435 REGULATION OF FIBROBLAST APOPTOTIC PROCESS 2 14 0.0005914 0.006198
436 REGULATION OF HORMONE SECRETION 5 262 0.0005839 0.006198
437 ESTABLISHMENT OF NUCLEUS LOCALIZATION 2 14 0.0005914 0.006198
438 T CELL MIGRATION 2 14 0.0005914 0.006198
439 CARDIOLIPIN METABOLIC PROCESS 2 14 0.0005914 0.006198
440 REGULATION OF PROTEIN KINASE C SIGNALING 2 14 0.0005914 0.006198
441 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 2 14 0.0005914 0.006198
442 ARACHIDONATE TRANSPORT 2 14 0.0005914 0.006198
443 REGULATION OF MUSCLE ADAPTATION 3 63 0.0005897 0.006198
444 RESPONSE TO OSMOTIC STRESS 3 63 0.0005897 0.006198
445 CELLULAR RESPONSE TO EXTERNAL STIMULUS 5 264 0.0006043 0.006304
446 AGING 5 264 0.0006043 0.006304
447 EMBRYONIC ORGAN DEVELOPMENT 6 406 0.0006238 0.006493
448 REGULATION OF MUSCLE CELL DIFFERENTIATION 4 152 0.0006538 0.006776
449 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 4 152 0.0006538 0.006776
450 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 8 750 0.0006575 0.006799
451 EPITHELIUM DEVELOPMENT 9 945 0.0006656 0.006867
452 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 2 15 0.0006813 0.0069
453 REGULATION OF HEAT GENERATION 2 15 0.0006813 0.0069
454 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 2 15 0.0006813 0.0069
455 POSITIVE REGULATION OF INSULIN SECRETION 3 66 0.0006758 0.0069
456 RESPONSE TO RADIATION 6 413 0.0006821 0.0069
457 RESPIRATORY BURST 2 15 0.0006813 0.0069
458 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 2 15 0.0006813 0.0069
459 REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 2 15 0.0006813 0.0069
460 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 3 66 0.0006758 0.0069
461 POSITIVE REGULATION OF NEURON DEATH 3 67 0.0007062 0.007081
462 PROTEIN IMPORT 4 155 0.0007035 0.007081
463 CELL AGING 3 67 0.0007062 0.007081
464 REGULATION OF CELL PROJECTION ASSEMBLY 4 155 0.0007035 0.007081
465 PROTEIN LOCALIZATION TO NUCLEUS 4 156 0.0007206 0.007211
466 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 3 68 0.0007374 0.007363
467 RESPONSE TO PURINE CONTAINING COMPOUND 4 158 0.0007558 0.00753
468 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 5 278 0.0007628 0.007584
469 POSITIVE REGULATION OF AXONOGENESIS 3 69 0.0007695 0.007634
470 SECRETION 7 588 0.0007777 0.007651
471 POSITIVE REGULATION OF TELOMERE CAPPING 2 16 0.0007773 0.007651
472 POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY 2 16 0.0007773 0.007651
473 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 2 16 0.0007773 0.007651
474 RESPONSE TO LIGHT STIMULUS 5 280 0.0007878 0.007733
475 MUSCLE SYSTEM PROCESS 5 282 0.0008134 0.007967
476 CELL CHEMOTAXIS 4 162 0.0008297 0.00811
477 POSITIVE REGULATION OF HEMOPOIESIS 4 163 0.0008489 0.008247
478 CELLULAR RESPONSE TO BIOTIC STIMULUS 4 163 0.0008489 0.008247
479 VASCULAR PROCESS IN CIRCULATORY SYSTEM 4 163 0.0008489 0.008247
480 ANATOMICAL STRUCTURE HOMEOSTASIS 5 285 0.0008529 0.008267
481 MUSCLE STRUCTURE DEVELOPMENT 6 432 0.000862 0.008338
482 REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 2 17 0.0008795 0.008386
483 REGULATION OF CHROMATIN BINDING 2 17 0.0008795 0.008386
484 POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 2 17 0.0008795 0.008386
485 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 2 17 0.0008795 0.008386
486 NEGATIVE REGULATION OF ANOIKIS 2 17 0.0008795 0.008386
487 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 2 17 0.0008795 0.008386
488 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 2 17 0.0008795 0.008386
489 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 9 983 0.0008816 0.008389
490 REGULATION OF DEVELOPMENTAL GROWTH 5 289 0.0009078 0.008602
491 REGULATION OF ORGAN GROWTH 3 73 0.0009068 0.008602
492 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 4 167 0.0009291 0.008787
493 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 3 74 0.0009434 0.008886
494 REGULATION OF ACUTE INFLAMMATORY RESPONSE 3 74 0.0009434 0.008886
495 REGULATION OF AXONOGENESIS 4 168 0.00095 0.00893
496 SENSORY PERCEPTION OF PAIN 3 75 0.0009809 0.009147
497 GRANULOCYTE MIGRATION 3 75 0.0009809 0.009147
498 CELLULAR GLUCOSE HOMEOSTASIS 3 75 0.0009809 0.009147
499 MULTI ORGANISM BEHAVIOR 3 75 0.0009809 0.009147
500 GLUCOSE HOMEOSTASIS 4 170 0.0009926 0.009219
501 CARBOHYDRATE HOMEOSTASIS 4 170 0.0009926 0.009219
NumGOOverlapSizeP ValueAdj. P Value
1 PHOSPHOLIPASE A2 ACTIVITY 9 31 5.046e-17 4.688e-14
2 KINASE ACTIVITY 21 842 5.625e-16 2.159e-13
3 PHOSPHOLIPASE ACTIVITY 11 94 6.971e-16 2.159e-13
4 LIPASE ACTIVITY 11 117 8.388e-15 1.948e-12
5 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 21 992 1.45e-14 2.694e-12
6 RIBONUCLEOTIDE BINDING 25 1860 5.551e-13 8.595e-11
7 RECEPTOR SIGNALING PROTEIN ACTIVITY 10 172 1.97e-11 2.615e-09
8 PROTEIN KINASE ACTIVITY 15 640 4.804e-11 5.579e-09
9 CARBOXYLIC ESTER HYDROLASE ACTIVITY 9 135 6.393e-11 6.599e-09
10 PROTEIN SERINE THREONINE KINASE ACTIVITY 13 445 7.942e-11 7.378e-09
11 MAP KINASE ACTIVITY 5 14 1.918e-10 1.62e-08
12 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 7 70 5.583e-10 4.322e-08
13 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 6 43 1.299e-09 9.282e-08
14 HYDROLASE ACTIVITY ACTING ON ESTER BONDS 14 739 3.761e-09 2.268e-07
15 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 6 51 3.777e-09 2.268e-07
16 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 7 92 3.907e-09 2.268e-07
17 ENZYME BINDING 20 1737 4.455e-09 2.434e-07
18 MAP KINASE KINASE ACTIVITY 4 12 1.98e-08 1.022e-06
19 ADENYL NUCLEOTIDE BINDING 18 1514 2.139e-08 1.046e-06
20 KINASE BINDING 12 606 3.663e-08 1.702e-06
21 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 4 16 7.224e-08 3.196e-06
22 PHOSPHATASE BINDING 7 162 1.979e-07 8.355e-06
23 KINASE REGULATOR ACTIVITY 7 186 5.049e-07 2.039e-05
24 INSULIN RECEPTOR SUBSTRATE BINDING 3 11 2.695e-06 0.0001043
25 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 4 39 3.124e-06 0.0001161
26 CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY 3 12 3.587e-06 0.0001282
27 CALMODULIN BINDING 6 179 6.838e-06 0.0002353
28 PROTEIN PHOSPHATASE BINDING 5 120 1.483e-05 0.0004922
29 SIGNAL TRANSDUCER ACTIVITY 15 1731 2.22e-05 0.000711
30 CALCIUM ION BINDING 9 697 6.919e-05 0.002142
31 MOLECULAR FUNCTION REGULATOR 12 1353 0.0001433 0.004294
32 SCAFFOLD PROTEIN BINDING 3 45 0.0002178 0.006322
NumGOOverlapSizeP ValueAdj. P Value
1 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 7 20 3.984e-14 2.327e-11
2 EXTRINSIC COMPONENT OF MEMBRANE 10 252 8.389e-10 2.449e-07
3 CELL SUBSTRATE JUNCTION 10 398 6.535e-08 1.272e-05
4 ANCHORING JUNCTION 10 489 4.388e-07 6.406e-05
5 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 7 237 2.552e-06 0.0002981
6 CELL JUNCTION 13 1151 5.499e-06 0.0004588
7 LAMELLIPODIUM 6 172 5.438e-06 0.0004588
8 GOLGI APPARATUS 14 1445 1.292e-05 0.0009432
9 MAST CELL GRANULE 3 21 2.133e-05 0.001384
10 CELL LEADING EDGE 7 350 3.219e-05 0.00188
11 PLASMA MEMBRANE RAFT 4 86 7.37e-05 0.003913
12 CYTOSKELETON 15 1967 9.787e-05 0.004438
13 MEMBRANE MICRODOMAIN 6 288 9.879e-05 0.004438
14 EARLY ENDOSOME 6 301 0.0001258 0.005247
15 VACUOLE 11 1180 0.0001854 0.007219

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04370_VEGF_signaling_pathway 52 76 7.211e-137 1.298e-134
2 hsa04664_Fc_epsilon_RI_signaling_pathway 34 79 1.837e-72 1.653e-70
3 hsa04014_Ras_signaling_pathway 33 236 1.462e-51 8.773e-50
4 hsa04662_B_cell_receptor_signaling_pathway 25 75 1.104e-48 4.969e-47
5 hsa04660_T_cell_receptor_signaling_pathway 26 108 1.888e-46 6.797e-45
6 hsa04010_MAPK_signaling_pathway 31 268 2.209e-45 6.628e-44
7 hsa04650_Natural_killer_cell_mediated_cytotoxicity 26 136 1.507e-43 3.875e-42
8 hsa04912_GnRH_signaling_pathway 23 101 3.18e-40 7.156e-39
9 hsa04666_Fc_gamma_R.mediated_phagocytosis 22 95 1.357e-38 2.715e-37
10 hsa04722_Neurotrophin_signaling_pathway 23 127 1.078e-37 1.94e-36
11 hsa04012_ErbB_signaling_pathway 21 87 3.248e-37 5.315e-36
12 hsa04730_Long.term_depression 19 70 1.047e-34 1.571e-33
13 hsa04510_Focal_adhesion 22 200 6.383e-31 8.839e-30
14 hsa04670_Leukocyte_transendothelial_migration 19 117 5.302e-30 6.817e-29
15 hsa04380_Osteoclast_differentiation 19 128 3.305e-29 3.966e-28
16 hsa04062_Chemokine_signaling_pathway 20 189 1.117e-27 1.257e-26
17 hsa04151_PI3K_AKT_signaling_pathway 23 351 4.485e-27 4.748e-26
18 hsa04620_Toll.like_receptor_signaling_pathway 16 102 5.454e-25 5.454e-24
19 hsa04810_Regulation_of_actin_cytoskeleton 19 214 8.992e-25 8.518e-24
20 hsa04914_Progesterone.mediated_oocyte_maturation 15 87 4.175e-24 3.758e-23
21 hsa04270_Vascular_smooth_muscle_contraction 16 116 4.879e-24 4.182e-23
22 hsa04910_Insulin_signaling_pathway 16 138 9.056e-23 7.409e-22
23 hsa04960_Aldosterone.regulated_sodium_reabsorption 12 42 2.533e-22 1.982e-21
24 hsa00592_alpha.Linolenic_acid_metabolism 10 20 1.018e-21 7.638e-21
25 hsa04360_Axon_guidance 15 130 2.488e-21 1.791e-20
26 hsa00591_Linoleic_acid_metabolism 10 30 1.625e-19 1.125e-18
27 hsa04972_Pancreatic_secretion 13 101 3.37e-19 2.247e-18
28 hsa04150_mTOR_signaling_pathway 11 52 6.601e-19 4.244e-18
29 hsa00565_Ether_lipid_metabolism 10 36 1.359e-18 8.435e-18
30 hsa00590_Arachidonic_acid_metabolism 11 59 3.018e-18 1.811e-17
31 hsa04210_Apoptosis 12 89 4.984e-18 2.894e-17
32 hsa04975_Fat_digestion_and_absorption 10 46 2.138e-17 1.203e-16
33 hsa04720_Long.term_potentiation 11 70 2.286e-17 1.247e-16
34 hsa04070_Phosphatidylinositol_signaling_system 11 78 8.094e-17 4.285e-16
35 hsa04973_Carbohydrate_digestion_and_absorption 9 44 1.73e-15 8.899e-15
36 hsa00564_Glycerophospholipid_metabolism 10 80 8.091e-15 4.046e-14
37 hsa04540_Gap_junction 9 90 1.577e-12 7.67e-12
38 hsa04916_Melanogenesis 9 101 4.563e-12 2.162e-11
39 hsa04310_Wnt_signaling_pathway 10 151 5.372e-12 2.479e-11
40 hsa04630_Jak.STAT_signaling_pathway 8 155 6.118e-09 2.753e-08
41 hsa00562_Inositol_phosphate_metabolism 6 57 7.521e-09 3.302e-08
42 hsa04020_Calcium_signaling_pathway 8 177 1.734e-08 7.431e-08
43 hsa04530_Tight_junction 7 133 5.116e-08 2.142e-07
44 hsa04621_NOD.like_receptor_signaling_pathway 5 59 4.391e-07 1.796e-06
45 hsa04320_Dorso.ventral_axis_formation 4 25 4.935e-07 1.974e-06
46 hsa04520_Adherens_junction 5 73 1.282e-06 5.016e-06
47 hsa04114_Oocyte_meiosis 5 114 1.156e-05 4.428e-05
48 hsa04622_RIG.I.like_receptor_signaling_pathway 3 71 0.0008364 0.003136
49 hsa04144_Endocytosis 3 203 0.01581 0.05722
50 hsa04971_Gastric_acid_secretion 2 74 0.01589 0.05722
51 hsa04350_TGF.beta_signaling_pathway 2 85 0.02063 0.07281
52 hsa04970_Salivary_secretion 2 89 0.02248 0.07782

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MAGI2-AS3

hsa-miR-149-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-455-5p;hsa-miR-590-3p 10 KDR Sponge network -0.939 4.0E-5 -0.064 0.72302 0.661
2

MAGI2-AS3

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-424-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-93-5p 25 PIK3R1 Sponge network -0.939 4.0E-5 -1.219 0 0.589
3

MAGI2-AS3

hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-27b-5p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-3613-5p;hsa-miR-7-1-3p 20 NFATC2 Sponge network -0.939 4.0E-5 -1.255 0.00017 0.524
4

RP11-193H5.1

hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-2355-5p;hsa-miR-29a-5p;hsa-miR-320a;hsa-miR-7-1-3p 10 NFATC2 Sponge network -0.426 0.01062 -1.255 0.00017 0.518
5

RP11-815I9.4

hsa-miR-103a-3p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-29b-3p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-361-3p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-664a-3p 14 NFAT5 Sponge network 0.004 0.98116 -0.144 0.16169 0.517
6

RP11-193H5.1

hsa-miR-130a-3p;hsa-miR-16-2-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-24-1-5p;hsa-miR-29a-5p;hsa-miR-29b-2-5p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-362-5p;hsa-miR-374a-3p;hsa-miR-501-5p 12 MAPK1 Sponge network -0.426 0.01062 -0.025 0.75566 0.487
7

RP11-594N15.3

hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-320b;hsa-miR-93-5p 15 PIK3R1 Sponge network -2.86 0 -1.219 0 0.483
8 SNHG14 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-455-3p;hsa-miR-584-5p;hsa-miR-589-3p;hsa-miR-629-3p 11 PIK3R1 Sponge network -1.125 0.0001 -1.219 0 0.482
9

AC007743.1

hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-424-5p;hsa-miR-584-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p 13 PIK3R1 Sponge network -1.053 0.00923 -1.219 0 0.478
10 CTA-221G9.11 hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-450b-5p;hsa-miR-629-3p;hsa-miR-93-5p 10 PIK3R1 Sponge network -2.198 0 -1.219 0 0.477
11 RP1-193H18.2 hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-455-3p;hsa-miR-584-5p;hsa-miR-589-3p;hsa-miR-96-5p 11 PIK3R1 Sponge network -1.539 0 -1.219 0 0.476
12 AC108142.1 hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-362-5p;hsa-miR-374a-5p;hsa-miR-429;hsa-miR-532-3p 10 PRKCA Sponge network 2.31 0 0.318 0.04622 0.474
13

RP11-193H5.1

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-362-5p;hsa-miR-374a-3p;hsa-miR-500a-5p;hsa-miR-576-5p 15 NFAT5 Sponge network -0.426 0.01062 -0.144 0.16169 0.472
14

RP11-400K9.4

hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-20a-5p;hsa-miR-324-3p;hsa-miR-93-5p 10 PIK3R1 Sponge network -0.304 0.38627 -1.219 0 0.469
15 PWAR6 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-629-3p 11 PIK3R1 Sponge network -1.629 0 -1.219 0 0.466
16

RP11-815I9.4

hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-589-3p;hsa-miR-590-5p 11 PIK3R1 Sponge network 0.004 0.98116 -1.219 0 0.464
17

SH3RF3-AS1

hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-7-1-3p 15 NFATC2 Sponge network -0.175 0.58985 -1.255 0.00017 0.463
18 RP11-284N8.3 hsa-miR-103a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-455-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 12 PIK3R1 Sponge network 0.003 0.99478 -1.219 0 0.457
19

BHLHE40-AS1

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-450b-5p;hsa-miR-590-5p;hsa-miR-96-5p 10 PIK3R1 Sponge network -0.932 0 -1.219 0 0.438
20

SH3RF3-AS1

hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-222-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-5p 13 PIK3R1 Sponge network -0.175 0.58985 -1.219 0 0.435
21 ZNF667-AS1 hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-96-5p 14 PIK3R1 Sponge network -1.395 0 -1.219 0 0.434
22

CTD-2015G9.2

hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-7-1-3p 10 NFATC2 Sponge network -3.112 5.0E-5 -1.255 0.00017 0.432
23

RP11-774O3.3

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-424-5p;hsa-miR-589-3p 15 PIK3R1 Sponge network -1.712 0 -1.219 0 0.415
24

AF127936.7

hsa-miR-17-3p;hsa-miR-181c-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-362-5p;hsa-miR-374a-5p;hsa-miR-532-3p 12 PRKCA Sponge network 0.453 0.00811 0.318 0.04622 0.412
25

SH3RF3-AS1

hsa-miR-103a-2-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-1976;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-2-5p;hsa-miR-339-5p;hsa-miR-505-5p 10 PRKCA Sponge network -0.175 0.58985 0.318 0.04622 0.404
26

RP11-166D19.1

hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-27b-5p;hsa-miR-33a-3p;hsa-miR-3613-5p;hsa-miR-484;hsa-miR-7-1-3p 14 NFATC2 Sponge network -0.882 5.0E-5 -1.255 0.00017 0.403
27

RP11-166D19.1

hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-324-3p;hsa-miR-429;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-96-5p 19 PIK3R1 Sponge network -0.882 5.0E-5 -1.219 0 0.401
28

MAGI2-AS3

hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-205-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-429;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-944 10 PRKCB Sponge network -0.939 4.0E-5 -0.01 0.96606 0.401
29

CTD-2015G9.2

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-450b-5p;hsa-miR-589-3p;hsa-miR-93-5p 16 PIK3R1 Sponge network -3.112 5.0E-5 -1.219 0 0.397
30

RP4-798P15.3

hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-96-5p 14 PIK3R1 Sponge network -1.213 0.00098 -1.219 0 0.393
31

AC007743.1

hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-29a-5p;hsa-miR-7-1-3p 10 NFATC2 Sponge network -1.053 0.00923 -1.255 0.00017 0.386
32 CTD-2135D7.5 hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-185-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-450b-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p 11 PIK3R1 Sponge network -2.579 0.0001 -1.219 0 0.379
33

LINC00900

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-424-5p;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-93-5p 19 PIK3R1 Sponge network -1.803 0 -1.219 0 0.373
34

AC003090.1

hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-424-5p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-93-5p;hsa-miR-96-5p 18 PIK3R1 Sponge network -4.323 0 -1.219 0 0.369
35 RP11-757G1.6 hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-93-5p 11 PIK3R1 Sponge network -1.346 0.00088 -1.219 0 0.367
36

CTD-2015G9.2

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-361-3p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-576-5p;hsa-miR-93-5p 17 NFAT5 Sponge network -3.112 5.0E-5 -0.144 0.16169 0.362
37

RP4-798P15.3

hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-29a-5p;hsa-miR-31-3p;hsa-miR-484;hsa-miR-7-1-3p 13 NFATC2 Sponge network -1.213 0.00098 -1.255 0.00017 0.362
38

LINC00702

hsa-miR-17-3p;hsa-miR-183-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-339-5p;hsa-miR-500a-5p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p 14 PRKCA Sponge network -0.573 0.0699 0.318 0.04622 0.359
39

RP11-594N15.3

hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-27b-5p;hsa-miR-320b;hsa-miR-3607-3p;hsa-miR-484 14 NFATC2 Sponge network -2.86 0 -1.255 0.00017 0.353
40

MAGI2-AS3

hsa-miR-103a-2-5p;hsa-miR-17-3p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-1976;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-2-5p;hsa-miR-27b-5p;hsa-miR-339-5p;hsa-miR-3607-3p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-500a-5p;hsa-miR-501-5p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p 20 PRKCA Sponge network -0.939 4.0E-5 0.318 0.04622 0.351
41

EMX2OS

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-324-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-93-5p 22 PIK3R1 Sponge network -1.459 1.0E-5 -1.219 0 0.349
42

MIR497HG

hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-455-3p;hsa-miR-584-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-96-5p 13 PIK3R1 Sponge network -1.263 0.00248 -1.219 0 0.343
43

LINC00284

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-424-5p;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-93-5p 17 PIK3R1 Sponge network -4.159 0 -1.219 0 0.333
44 DNM3OS hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-96-5p 11 PIK3R1 Sponge network 0.932 0.00442 -1.219 0 0.328
45

AF127936.7

hsa-miR-155-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-181c-5p;hsa-miR-25-3p;hsa-miR-27b-5p;hsa-miR-320a;hsa-miR-361-3p;hsa-miR-362-5p 11 NFAT5 Sponge network 0.453 0.00811 -0.144 0.16169 0.321
46 DLGAP1-AS5 hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-589-3p 10 PIK3R1 Sponge network -6.207 0 -1.219 0 0.315
47 RP11-58E21.3 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-181c-5p;hsa-miR-194-5p;hsa-miR-25-3p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-582-3p;hsa-miR-93-5p 10 NFAT5 Sponge network 0.445 0.04375 -0.144 0.16169 0.308
48

TPTEP1

hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-424-5p;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-93-5p 13 PIK3R1 Sponge network -2.193 0 -1.219 0 0.308
49 LINC00957 hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-222-3p;hsa-miR-424-5p;hsa-miR-450b-5p;hsa-miR-455-3p 10 PIK3R1 Sponge network -0.677 2.0E-5 -1.219 0 0.306
50

RP11-193H5.1

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-29b-3p;hsa-miR-320a 11 PIK3R1 Sponge network -0.426 0.01062 -1.219 0 0.297
51 LINC00675 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-181a-5p;hsa-miR-194-5p;hsa-miR-21-5p;hsa-miR-25-3p 10 NFAT5 Sponge network -4.584 0 -0.144 0.16169 0.295
52

LINC00702

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-222-3p;hsa-miR-224-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-93-5p;hsa-miR-96-5p 21 PIK3R1 Sponge network -0.573 0.0699 -1.219 0 0.294
53

EMX2OS

hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-27b-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-484;hsa-miR-7-1-3p;hsa-miR-9-5p 19 NFATC2 Sponge network -1.459 1.0E-5 -1.255 0.00017 0.292
54

RP4-798P15.3

hsa-miR-103a-3p;hsa-miR-148b-5p;hsa-miR-155-5p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-590-5p 14 NFAT5 Sponge network -1.213 0.00098 -0.144 0.16169 0.29
55

MIR22HG

hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-181c-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-582-5p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 17 NFAT5 Sponge network -0.601 4.0E-5 -0.144 0.16169 0.288
56

RP11-166D19.1

hsa-miR-103a-2-5p;hsa-miR-17-3p;hsa-miR-183-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-2-5p;hsa-miR-27b-5p;hsa-miR-339-5p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-92a-3p;hsa-miR-93-3p 13 PRKCA Sponge network -0.882 5.0E-5 0.318 0.04622 0.285
57

RP11-193H5.1

hsa-miR-103a-2-5p;hsa-miR-186-5p;hsa-miR-24-2-5p;hsa-miR-29b-2-5p;hsa-miR-339-5p;hsa-miR-362-5p;hsa-miR-500a-5p;hsa-miR-501-5p;hsa-miR-505-5p;hsa-miR-93-3p 10 PRKCA Sponge network -0.426 0.01062 0.318 0.04622 0.281
58

CASC15

hsa-miR-17-3p;hsa-miR-1976;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-429;hsa-miR-590-3p 10 PRKCA Sponge network 1.485 0 0.318 0.04622 0.269
59 CTC-297N7.7 hsa-miR-103a-3p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-96-5p 11 PIK3R1 Sponge network -1.666 0.01558 -1.219 0 0.267
60 CTD-2554C21.3 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-455-3p;hsa-miR-629-3p 10 PIK3R1 Sponge network -2.118 6.0E-5 -1.219 0 0.267
61

CTD-2008P7.9

hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-500a-5p;hsa-miR-576-5p 16 NFAT5 Sponge network -1.202 0.00093 -0.144 0.16169 0.254

Quest ID: 4f19c35e41608df6109704db00798d5b